Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT Pharmaceutical Investing
FDA Approves BriaCell's Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer Pharmaceutical Investing
FDA GRANTS FULL APPROVAL FOR BLINCYTO® TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Market News
